Home Bayer's Finerenone Significantly Reduced Kidney Function Decline and Cardiovascular-Kidney Outcomes in Non-Diabetic CKD

Bayer's Finerenone Significantly Reduced Kidney Function Decline and Cardiovascular-Kidney Outcomes in Non-Diabetic CKD

Jun 05, 2026 18:38 CST Updated 19:03